Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Multicentre Study on Efficacy and Safety of Oral Quetiapine (Seroquel XR) in Adults With Schizophrenia

NCT00852631 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00852631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00852631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Multicentre Study on Efficacy and Safety of Oral Quetiapine (Seroquel XR) in Adults With Schizophrenia
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Terminated
Start date
February 28, 2009
Completion date
May 31, 2010
Enrollment
28 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia